What is ANI Pharmaceuticals's restricted cash?

ANI Pharmaceuticals (ANIP) reported restricted cash of $36K in Q1 2026.

How has ANI Pharmaceuticals's restricted cash changed year-over-year?

ANI Pharmaceuticals's restricted cash increased by 5.9% year-over-year, from $34K to $36K.

What is the long-term trend for ANI Pharmaceuticals's restricted cash?

Over 5 years (2020 to 2025), ANI Pharmaceuticals's restricted cash has grown at a -62.7% compound annual growth rate (CAGR), from $5M to $36K.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

ANI Pharmaceuticals ANIP Restricted Cash

Restricted Cash at other companies

Amneal Pharmaceuticals, Inc.AMRX

$4.17M-36.6%

ALN

Alnylam PharmaceuticalsALNY

$1.64M-36.8%

Aurinia PharmaceuticalsAUPH

$259K-17.8%

Mirum Pharmaceuticals, Inc.MIRM

$1.73M+308%

LQD

Liquidia CorporationLQDA

$3.5M—

ViatrisVTRS

——

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.89B+18.3%

Enterprise value$1.88B+5.8%

P/E20.5×—

P/S2×-0.3×

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's restricted cash?: ANI Pharmaceuticals (ANIP) reported restricted cash of $36K in Q1 2026.
How has ANI Pharmaceuticals's restricted cash changed year-over-year?: ANI Pharmaceuticals's restricted cash increased by 5.9% year-over-year, from $34K to $36K.
What is the long-term trend for ANI Pharmaceuticals's restricted cash?: Over 5 years (2020 to 2025), ANI Pharmaceuticals's restricted cash has grown at a -62.7% compound annual growth rate (CAGR), from $5M to $36K.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.